These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37442396)

  • 1. The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice.
    Espina M; Di Franco N; Brañas-Navarro M; Navarro IR; Brito V; Lopez-Molina L; Costas-Insua C; Guzmán M; Ginés S
    Neurobiol Dis; 2023 Aug; 184():106225. PubMed ID: 37442396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity.
    Anglada-Huguet M; Vidal-Sancho L; Giralt A; García-Díaz Barriga G; Xifró X; Alberch J
    Neurobiol Dis; 2016 Nov; 95():22-34. PubMed ID: 26369879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction.
    Vidal-Sancho L; Fernández-García S; Solés-Tarrés I; Alberch J; Xifró X
    Mol Neurobiol; 2020 Nov; 57(11):4549-4562. PubMed ID: 32757160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease.
    Cabezas-Llobet N; Vidal-Sancho L; Masana M; Fournier A; Alberch J; Vaudry D; Xifró X
    Mol Neurobiol; 2018 Nov; 55(11):8263-8277. PubMed ID: 29526016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in BiP availability reveal hypersensitivity to acute endoplasmic reticulum stress in cells expressing mutant huntingtin.
    Lajoie P; Snapp EL
    J Cell Sci; 2011 Oct; 124(Pt 19):3332-43. PubMed ID: 21896647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of hippocampal mHTT aggregates leads to impaired spatial memory, hippocampal activation and adult neurogenesis.
    Schwab LC; Richetin K; Barker RA; Déglon N
    Neurobiol Dis; 2017 Jun; 102():105-112. PubMed ID: 28286179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
    Dufour BD; McBride JL
    Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Visualisation of Abnormal Dendritic Spine Morphology in the Hippocampus of the R6/2 Transgenic Mouse Model of Huntington's Disease.
    Bulley SJ; Drew CJ; Morton AJ
    J Huntingtons Dis; 2012; 1(2):267-73. PubMed ID: 25063335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
    Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
    J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.
    Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG
    J Neurosci; 2023 Jun; 43(23):4365-4377. PubMed ID: 37055181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of therapy by MK-28 PERK activation in the Huntington's disease R6/2 mouse model.
    Shacham T; Offen D; Lederkremer GZ
    Neurotherapeutics; 2024 Mar; 21(2):e00335. PubMed ID: 38368172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
    Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J
    Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease.
    Murmu RP; Li W; Holtmaat A; Li JY
    J Neurosci; 2013 Aug; 33(32):12997-3009. PubMed ID: 23926255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
    Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
    Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy.
    Vidal RL; Figueroa A; Court FA; Thielen P; Molina C; Wirth C; Caballero B; Kiffin R; Segura-Aguilar J; Cuervo AM; Glimcher LH; Hetz C
    Hum Mol Genet; 2012 May; 21(10):2245-62. PubMed ID: 22337954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring GABAergic inhibition rescues memory deficits in a Huntington's disease mouse model.
    Dargaei Z; Bang JY; Mahadevan V; Khademullah CS; Bedard S; Parfitt GM; Kim JC; Woodin MA
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1618-E1626. PubMed ID: 29382760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.
    Murphy KP; Carter RJ; Lione LA; Mangiarini L; Mahal A; Bates GP; Dunnett SB; Morton AJ
    J Neurosci; 2000 Jul; 20(13):5115-23. PubMed ID: 10864968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin ameliorates motor and cognitive deficits and neuropathology in R6/2 mouse model of Huntington's disease by decreasing mutant huntingtin protein level and normalizing NF-κB signaling pathway.
    Liu SY; Yu XL; Zhu J; Liu XM; Zhang Y; Dong QX; Ma S; Liu RT
    Brain Res; 2018 Oct; 1697():21-33. PubMed ID: 29902468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.